Wilson Sonsini’s 2020 Technology and Life Sciences IPO Report presents analysis and data related to the pricing of 123 initial public offerings completed by U.S.-based technology and life sciences companies between January 1 and December 31, 2020. The report includes IPO filing, pricing, and value statistics for both sectors; governance and board of director details; ownership and structure factors; and defensive measure data points. It also considers concurrent private placements, indications of interest, direct listings, and special purpose acquisition companies.
As the report illustrates, 2020 was more active than 2019 for technology and life sciences IPOs, despite the COVID-19 pandemic that many expected to slow IPO activity. Instead, the total number of IPOs increased by more than 40 percent over the previous year, while the number of IPOs in the second half of 2020 increased by nearly 150 percent.
Please see full publication below for more information.
